Zacks Research Analysts Raise Earnings Estimates for NOVONIX

Key Points

• Zacks Research raised NOVONIX’s FY2026 EPS estimate to a loss of $2.70 per share from a previous estimate of $4.90, though the broader consensus remains at a $4.90-per-share loss.
• NOVONIX shares opened at $2.74, near their 12-month low of $2.65 and well below their 50-day and 200-day moving averages of $3.99 and $5.96, respectively.
• Investor sentiment remains negative: Weiss Ratings downgraded the stock to “sell (e+),” and MarketBeat reports an overall “Sell” rating. Institutional ownership is minimal at just 0.06%.

NOVONIX Limited Sponsored ADR (NASDAQ:NVX - Free Report) - Equities research analysts at Zacks Research increased their FY2026 earnings per share (EPS) estimates for shares of NOVONIX in a research note issued to investors on Thursday, September 3rd. Zacks Research analyst M. Marin now anticipates that the company will post earnings of ($2.70) per share for the year, up from their prior estimate of ($4.90). The consensus estimate for NOVONIX's current full-year earnings is ($4.90) per share.

Separately, Weiss Ratings downgraded shares of NOVONIX from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of "Sell".

NOVONIX Price Performance

NASDAQ NVX opened at $2.74 on Thursday. The business has a fifty day simple moving average of $3.99 and a 200 day simple moving average of $5.96. NOVONIX has a 12 month low of $2.65 and a 12 month high of $38.60. The company has a debt-to-equity ratio of 0.20, a current ratio of 0.97 and a quick ratio of 0.97.

NOVONIX (NASDAQ:NVX - Get Free Report) last posted its earnings results on Friday, July 31st. The company reported ($0.06) earnings per share for the quarter.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Jane Street Group LLC bought a new stake in shares of NOVONIX during the 4th quarter worth $1,063,000. XTX Topco Ltd raised its position in NOVONIX by 388.0% in the fourth quarter. XTX Topco Ltd now owns 270,796 shares of the company's stock worth $274,000 after acquiring an additional 215,305 shares during the period. SmartHarvest Portfolios LLC purchased a new position in NOVONIX in the first quarter valued at about $100,000. Citadel Advisors LLC boosted its stake in NOVONIX by 964.1% in the third quarter. Citadel Advisors LLC now owns 109,374 shares of the company's stock valued at $140,000 after acquiring an additional 99,095 shares during the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in shares of NOVONIX during the 4th quarter worth approximately $97,000. Institutional investors own 0.06% of the company's stock.

NOVONIX Company Profile

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company's primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.